Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
G Chir ; 26(1-2): 43-6, 2005.
Article in English | MEDLINE | ID: mdl-15847095

ABSTRACT

Malignant Fibrous Histiocytoma (MFH) rarely affects the abdomen and only a few cases arising in the mesentery have to date been discovered. In this paper, two cases of MFH of the mesentery are described and a review of the literature is reported.


Subject(s)
Histiocytoma, Benign Fibrous , Mesentery , Peritoneal Neoplasms , Aged , Aged, 80 and over , Female , Follow-Up Studies , Histiocytoma, Benign Fibrous/diagnostic imaging , Histiocytoma, Benign Fibrous/pathology , Histiocytoma, Benign Fibrous/surgery , Humans , Mesentery/pathology , Middle Aged , Peritoneal Neoplasms/diagnostic imaging , Peritoneal Neoplasms/pathology , Peritoneal Neoplasms/surgery , Prognosis , Radiography, Abdominal , Time Factors , Tomography, X-Ray Computed
2.
J Exp Clin Cancer Res ; 22(4): 649-50, 2003 Dec.
Article in English | MEDLINE | ID: mdl-15053311

ABSTRACT

Haemangiopericytoma (HPT) is a rare neoplasm that can occur in any part of the human body. In this report, we describe the case of a patient with sudden severe upper abdominal pain caused by primary HPT in the greater omentum.


Subject(s)
Abdomen, Acute/etiology , Hemangiopericytoma/complications , Omentum/pathology , Peritoneal Neoplasms/complications , Female , Hemangiopericytoma/pathology , Humans , Middle Aged , Peritoneal Neoplasms/pathology
3.
Minerva Chir ; 51(11): 911-8, 1996 Nov.
Article in Italian | MEDLINE | ID: mdl-9072718

ABSTRACT

It is a common opinion that the more often and the more rigorously the colon is examined, the more lesions will be discovered and diagnosed. However it has not been shown which methods of colonic examination and which regimen of surveillance should be used. Chart review was conducted on 481 patients who underwent curative resection for colorectal cancer between 1980 and 1990. Colonoscopy was performed preoperatively, after 12-15 months from surgical treatment, and then at an interval of 12-24 months, or when symptoms appeared. About ten percent of patients developed intraluminal recurrences, and more than 25% adenomatous polyps. More than one half of the metachronous lesions arise within the first 24 months. The median time to diagnosis was 25 months for intraluminal recurrences and 22 months for adenomatous polyps. Patients with left sited tumor at an advanced stage run a higher risk of developing recurrent intraluminal disease, and patients who presented associated polyps at the time of the operation for the index cancer have a higher risk of developing new polyps. About 50% of recurrences were detected when patients were asymptomatic. Colonoscopy must be performed within the first 12-15 months after operation, while an interval of 24 months between each examination seems sufficient to guarantee an early detection of metachronous lesion. Asymptomatic patients are more frequently reoperated for cure and thus have a better survival rate.


Subject(s)
Colonoscopy , Colorectal Neoplasms/diagnosis , Neoplasm Recurrence, Local/diagnosis , Neoplasms, Second Primary/diagnosis , Adult , Aged , Aged, 80 and over , Colorectal Neoplasms/surgery , Female , Follow-Up Studies , Humans , Male , Medical Records , Middle Aged , Predictive Value of Tests , Randomized Controlled Trials as Topic , Retrospective Studies , Time Factors
4.
Dis Colon Rectum ; 39(4): 388-93, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8878497

ABSTRACT

PURPOSE: The authors evaluate the effectiveness of routine colonoscopy and marker evaluation in diagnosis of intraluminal recurrent cancer. METHODS: Chart review was conducted on 481 patients who underwent curative resection for colorectal cancer between 1980 and 1990. Clinical visits were scheduled and carcinoembryonic antigen evaluation was performed every three months, and colonoscopy was performed preoperatively, 12 to 15 months after surgical treatment, and then with intervals of 12 to 24 months or when symptoms appeared. RESULTS: About 10 percent of patients developed intraluminal recurrences. More than one-half of metachronous lesions arose within the first 24 months, and median time to diagnosis was 25 months. Patients with left-sited tumors in the advanced stage had a higher risk of developing recurrent intraluminal disease. Twenty-nine patients underwent a second surgical operation, of which 17 cases were radical. In this group, the five-year survival was 70.6 percent, although no nonradically treated or nonresected patients survived longer than 31 months. Twenty-two patients were asymptomatic at time of diagnosis of recurrence, and of these, 12 patients underwent radical operation; on the other hand, of the 24 symptomatic patients, only 5 were treated radically. Carcinoembryonic antigen was the first sign of recurrence in eight cases. Colonoscopy must be performed within the first 12 to 15 months after operation, whereas an interval of 24 months between examinations seems sufficient to guarantee early detection of metachronous lesions. CONCLUSION: Serial tumor marker evaluation is of help in earlier diagnosis of local recurrences. Asymptomatic patients more frequently undergo another operation for cure and thus have a better survival rate.


Subject(s)
Colorectal Neoplasms/mortality , Neoplasm Recurrence, Local/diagnosis , Aged , Biomarkers, Tumor/blood , Carcinoembryonic Antigen/blood , Colonoscopy , Colorectal Neoplasms/diagnosis , Colorectal Neoplasms/surgery , Female , Follow-Up Studies , Humans , Male , Prognosis , Reoperation , Risk Factors , Survival Rate , Time Factors
5.
Ann Ital Chir ; 66(4): 543-50, 1995.
Article in Italian | MEDLINE | ID: mdl-8687008

ABSTRACT

From March 1992 to September 1994, 281 patients were submitted to laparoscopic cholecystectomy for cholelithiasis. 27 patients were admitted with diagnosis of acute cholecystitis and in 17 patients common duct stones were discovered and managed by ERCP before laparoscopic procedure. Surgical procedure was the standard one described by Cox. The mean duration of the operation was 60 minutes and was significantly related to the surgeon's experience; the incedence of conversion to open procedure was 5.7%. There was no postoperative mortality; the total morbility rate was 2.8%, with 3 major complications, and 5 minor complications.


Subject(s)
Cholecystectomy, Laparoscopic , Video Recording , Adolescent , Adult , Aged , Aged, 80 and over , Cholangiography , Cholangiopancreatography, Endoscopic Retrograde , Cholecystectomy, Laparoscopic/adverse effects , Cholecystitis/diagnostic imaging , Cholecystitis/surgery , Cholelithiasis/diagnostic imaging , Cholelithiasis/surgery , Evaluation Studies as Topic , Female , Humans , Male , Middle Aged
6.
Minerva Chir ; 49(11): 1083-8, 1994 Nov.
Article in Italian | MEDLINE | ID: mdl-7708228

ABSTRACT

Between 1989 and 1991, 66 women affected by breast cancer smaller than 2 cm in diameter, were treated with conservative procedure plus radiotherapy. Conservative procedure consisted in quadrantectomy and axillary dissection of the 3 axillary nodes levels. Neoplasms were grouped according to TNM classification. Eleven were classified as Tis, 9 as T1aN0M0, 12 as T1bN0M0, one case T1bN1M0, 24 as T1cN0M0 and finally 9 as T1cN1M0. Actuarial 5-year survival rate was related to TNM. It has been reported to be 100% in Tis and T1aN0M0 neoplasms; 91.7% in pT1bN0M0 tumors, 95.8% in pT1cN0M0 neoplasms, 55.6% in patients affected with pT1cN1M0 tumors. According to the relationship between receptor status of the neoplasm and survival, this was 88.9% in ER+ and 77.8% in ER- tumors, and 97.1% against 71.4% (p < 0.05) in PR+ and PR- neoplasms respectively. Two patients presented (3%) local recurrence which were treated by means of a tumorectomy and radiotherapy. Both patients are still living and disease free after 6 and 9 months from re-operation.


Subject(s)
Breast Neoplasms/surgery , Carcinoma in Situ/surgery , Carcinoma, Ductal, Breast/surgery , Carcinoma, Lobular/surgery , Adult , Aged , Aged, 80 and over , Breast/pathology , Breast Neoplasms/pathology , Breast Neoplasms/radiotherapy , Carcinoma in Situ/pathology , Carcinoma in Situ/radiotherapy , Carcinoma, Ductal, Breast/pathology , Carcinoma, Ductal, Breast/radiotherapy , Carcinoma, Lobular/pathology , Carcinoma, Lobular/radiotherapy , Female , Humans , Lymph Node Excision , Middle Aged , Neoplasm Recurrence, Local/surgery , Prognosis , Radiotherapy Dosage , Reoperation
SELECTION OF CITATIONS
SEARCH DETAIL
...